Renal artery stenting using gadodiamide arteriography in patients with baseline renal insufficiency

Journal of Endovascular Therapy

Volumn 11, Issue 5, 2004, Pages 553-559

  Harb, Tareq S ^a   Laird, John R ^a,b   Dieter, Robert S ^a   Reddy, Bhagat K ^a   Whitman, Donna ^a   Babrowicz, Joseph C ^a   Satler, Lowell F ^a  

^a GEORGETOWN UNIVERSITY   (United States)

^b WASHINGTON HOSPITAL CENTER   (United States)

Author keywords

Complication; Digital subtraction angiography; Gadodiamide; Gadolinium; Renal artery stenting; Renal insufficiency; Serum creatinine

Indexed keywords

CONTRAST MEDIUM; GADODIAMIDE;

ADULT; AGED; ARTERIOGRAPHY; ARTERY SURGERY; ARTICLE; CLINICAL ARTICLE; CREATININE BLOOD LEVEL; DISEASE ASSOCIATION; FEMALE; FOLLOW UP; HIGH RISK POPULATION; HUMAN; KIDNEY ARTERY STENOSIS; KIDNEY DISEASE; KIDNEY FAILURE; MALE; PRIORITY JOURNAL; RENAL ARTERY; STATISTICAL SIGNIFICANCE;

AGED; ANGIOGRAPHY; ANGIOPLASTY; BLOOD VESSEL PROSTHESIS IMPLANTATION; CONTRAST MEDIA; FEMALE; GADOLINIUM DTPA; HUMANS; KIDNEY FAILURE; MALE; RENAL ARTERY; RENAL ARTERY OBSTRUCTION; RETROSPECTIVE STUDIES; STENTS;

EID: 7244242276     PISSN: 15266028     EISSN: None     Source Type: Journal    
DOI: 10.1583/04-1234.1     Document Type: Article

References (21)

1. Watson PS, Hadjipetrou P, Cox SV, et al. Effect of renal artery stenting on renal function and size in patients with atherosclerotic renovascular disease. Circulation. 2000;102:1671-1677.
2. Isles CG, Robertson S, Hill D. Management of renovascular disease: a review of renal artery stenting in ten studies. QJM. 1999;92:159-167.
3. Rocha-Singh KJ, Ahuja RK, Sung CH, et al. Long-term renal function preservation after renal artery stenting in patients with progressive ischemic nephropathy. Catheter Cardiovasc Interv. 2002;57:135-141.
4. Dorros G, Jaff M, Mathiak L, et al. Four-year follow-up of Palmaz-Schatz stent revascularization as treatment for atherosclerotic renal artery stenosis. Circulation. 1998;98:642-647.
5. Zeller T, Frank U, Muller C, et al. Predictors of improved renal function after percutaneous stent-supported angioplasty of severe atherosclerotic ostial renal artery stenosis. Circulation. 2003;108:2244-2249.
6. Parfrey PS, Griffiths SM, Barrett BJ, et al. Contrast material-induced renal failure in patients with diabetes mellitus, renal insufficiency, or both. A prospective controlled study. N Engl J Med. 1989;320:143-149.
7. Levy EM, Viscoli CM, Horwitz RI. The effect of acute renal failure on mortality. A cohort analysis. JAMA. 1996;275:1489-1494.
8. Solomon R, Werner C, Mann D, et al. Effects of saline, mannitol, and furosemide to prevent acute decreases in renal function induced by radiocontrast agents. N Engl J Med. 1994;331:1416-1420.
9. Kay J, Chow WH, Chan TM, et al. Acetylcysteine for prevention of acute deterioration of renal function following elective coronary angiography and intervention: a randomized controlled trial. JAMA. 2003;289:553-558.
10. Lundby B, Berg KJ, Lien HH, et al. A double blind study to evaluate the tolerability of gadodiamide injection and its effect on renal function in patients undergoing cerebral magnetic resonance imaging. Br J Radiol. 1993;66:871-876.
11. Ghantous VE, Eisen TD, Sherman AH, et al. Evaluating patients with renal failure for renal artery stenosis with gadolinium-enhanced magnetic resonance angiography. Am J Kidney Dis. 1999;33:36-42.
12. Zeller T, Müller C, Frank U, et al. Gadodiamide as an alternative contrast agent during angioplasty in patients with contraindications to iodinated media. J Endovasc Ther. 2002;9:625-632.
13. Rieger J, Sitter T, Toepfer M, et al. Gadolinium as an alternative contrast agent for diagnostic and interventional angiographic procedures in patients with impaired renal function. Nephrol Dial Transplant. 2002;17:824-828.
14. Spinosa DJ, Matsumoto AH, Angle JF, et al. Use of gadopentetate dimeglumine as a contrast agent for percutaneous transluminal renal angioplasty and stent placement. Kidney Int. 1998;53:503-507.
15. Dinkel HP, Hoppe H, Baumgartner I, et al. Low-osmolar gadodiamide as alternative contrast agent for diagnostic angiography and angiographic interventions in patients with renal insufficiency (in German). Rofo Fortschr Geb Roentgenstr Neuen Bildgeb Verfahr. 2002;174:56-61.
16. Dangas G, Laird JR, Mehran R, et al. Intravascular ultrasound-guided renal artery stenting. J Endovasc Ther. 2001;8:238-247.
17. Aspelin P, Aubry P, Fransson SG, et al. Nephrotoxic effects in high-risk patients undergoing angiography. NEPHRIC Study Investigators. N Engl J Med. 2003;348:491-499.
18. Mueller C, Buerkle G, Buettner HJ, et al. Prevention of contrast media-associated nephropathy: randomized comparison of two hydration regimens in 1620 patients undergoing coronary angioplasty. Arch Intern Med. 2002;162:329-336.
19. Stone GW, McCullough PA, Tumlin JA, et al. Fenoldopam mesylate for the prevention of contrast-induced nephropathy: a randomized controlled trial. JAMA. 2003;290:2284-2291.
20. Marenzi G, Marana I, Lauri G, et al. The prevention of radiocontrast-agent-induced nephropathy by hemofiltration. N Engl J Med. 2003;349:1333-1340.
21. Omniscan (gadodiamide) package insert. Princeton, NJ: Amersham Health, Inc.; 2002.